PediRISE Program for Pediatric Cancer and Financial Hardship

This study, called PediRISE Feasibility, is looking at whether the PediRISE Resource Program can be successfully offered to families with children (ages 0-17) who have a new cancer diagnosis and are experiencing financial hardship. The PediRISE program provides direct cash payments twice a month and benefits counseling. The main goal is to see if families are interested in joining a study like this, where they have a 50/50 chance of receiving the PediRISE program or standard care. This study is currently recruiting about 40 children with cancer who have recently started treatment. Success for this study means a good number of families agree to participate and stay in the study for the full 6 months.

Study design
This is a pilot, multi-center, randomized study, meaning participants are randomly assigned to either the PediRISE Program Group or the Usual Care Group. About 40 children with cancer and their families will take part.
What's involved
Participation involves screening for eligibility, study visits, and completing surveys and questionnaires. Your involvement will last for about 6 months.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for about 6 months, with the participant attrition rate measured at this time.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06283251

PediRISE Feasibility

Recruiting
NAUp to 17InterventionalSupportive care
Dana-Farber Cancer Institute
~40 participants
Updated 2026-02-10 on ClinicalTrials.gov
What's tested:PediRISE Resource Program

At a glance

Recruiting sites
4 of 4 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Participant Consent Rate
Measured over 1 Day
+1 more outcome measured
Pediatric Cancer
Financial Stress
Financial Hardship
Disparities
4 sites across 3 states
Massachusetts2
California1
New York1
  • Kira Bona, MD, MPH · PRINCIPAL_INVESTIGATOR · Dana-Farber Cancer Institute

Opens a ready-to-send draft in your own email app — review before sending.

  • Participant Consent Rate1 Day

    The proportion of eligible participants who provide informed consent to participate in the randomized guaranteed income intervention.

  • Participant Attrition RateAt 6 months

    The proportion of participants who withdraw from the study, are lost to follow-up, or otherwise do not complete the assigned study procedures.